Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 05, 2021

SELL
$3.85 - $5.09 $323 - $427
-84 Closed
0 $0
Q2 2021

Aug 12, 2021

BUY
$4.03 - $7.57 $338 - $635
84 New
84 $0
Q1 2021

May 24, 2021

SELL
$6.8 - $9.16 $571 - $769
-84 Closed
0 $0
Q4 2020

Feb 09, 2021

SELL
$5.29 - $9.1 $2,645 - $4,550
-500 Reduced 85.62%
84 $1,000
Q3 2020

Nov 16, 2020

BUY
$5.41 - $9.45 $3,159 - $5,518
584 New
584 $5,000

About LogicBio Therapeutics, Inc.


  • Ticker LOGC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,962,700
  • Description
  • LogicBio Therapeutics, Inc., a genetic medicine company, focuses on developing and commercializing genome editing and gene therapy treatments using its GeneRide and sAAVy platforms. The company's GeneRide technology is a new approach to precise gene insertion harnessing a cell's natural deoxyribonucleic acid; and gene delivery platform, sAAVy is...
More about LOGC
Track This Portfolio

Track Advisory Services Network, LLC Portfolio

Follow Advisory Services Network, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisory Services Network, LLC with notifications on news.